Crescent Biopharma CBIO Cash Flow Statement (2013-2026)

NASDAQ CBIO
$16.23 -1.09 (-6.29%)
At close: Aug 20, 2026 · 4:00 PM EDT
1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-17.33M-17.42M-14.65M-13.27M-8.52M-10.24M-10.36M-8.26M-9.20M-9.08M-10.74M-10.10M-9.82M-17.87M-2.30M-51.31M-24.61M-90.40M-76.28M-24.84M
Depreciation and Depletion (Quarter)
0.07M0.06M0.06M0.05M0.05M0.05M0.04M0.04M0.04M0.02M0.01M0.01M0.00M0.03M0.05M0.06M0.07M
Share-based Compensation (Quarter)
1.59M1.32M78.00-32.000.91M0.90M0.03M0.02M0.89M0.91M1.19M1.21M8.83M1.23M0.40M6.92M4.75M4.11M3.96M
Asset Writedowns and Impairment (Quarter)
0.03M
Cash from Operations (Quarter)
-19.46M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges (Quarter)
0.19M0.19M0.20M0.20M0.21M0.21M0.22M0.22M0.23M0.19M0.17M0.17M0.02M0.09M0.10M0.10M0.10M
Depreciation & Amortization (CF) (Quarter)
0.07M0.06M0.06M0.05M0.05M0.05M0.04M0.04M0.04M0.02M0.01M0.01M0.00M0.03M0.05M0.06M0.07M
Change in Working Capital
Change in Receivables (Quarter)
-18.00M
Change in Account Payables (Quarter)
1.50M
Change in Accured Expenses (Quarter)
2.97M
Other Working Capital Changes (Quarter)
1.01M
Investing Activities
Capital Expenditures (Quarter)
0.01M
Cash from Investing Activities (Quarter)
1.76M
Financing Activities
Other financing activities (Quarter)
0.28M
Cash from Financing Activities (Quarter)
0.14M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
1.14M28.71M4.00M
Additional items
Change in Cash (Quarter)
-17.57M
Free Cash Flow (Quarter)
-19.48M
Net Cash Flow (Quarter)
-17.57M